6533b822fe1ef96bd127ce56

RESEARCH PRODUCT

Estradiol decreases xanthine dehydrogenase enzyme activity and protein expression innon-tumorigenicand malignant human mammary epithelial cells

Giuseppe CarrubaGennaro TaibiVitale MiceliConcetta M.a. NicotraLetizia Cocciadiferro

subject

CellRetinoic acidTretinoinBiologyBiochemistryGene Expression Regulation Enzymologicchemistry.chemical_compoundCell Line TumorSettore BIO/10 - BiochimicaRETINOIC ACIDmedicineHumansRNA MessengerMammary Glands Humanskin and connective tissue diseasesXanthine oxidaseXANTHINE OXIDASEESTRADIOLMolecular BiologyRetinolEpithelial CellsCell BiologyMolecular biologyEnzyme assayGene Expression Regulation NeoplasticRetinoic acid receptormedicine.anatomical_structurechemistryXanthine dehydrogenaseCell culturebiology.proteinXANTHINE DEHYDROGENASE

description

The retinoic acid deficiency in breast tumour epithelial cells has been ascribed to an insufficient expression of either the enzyme(s) involved in its biosynthesis or the cellular retinol binding protein (CRBP) or both. In an attempt to define the mechanisms underpinning retinoic acid deficiency in these cell model systems, we have investigated the potential regulatory effect of oestrogen (17β-estradiol) on one key player in retinoic acid biosynthesis, the xanthine dehydrogenase (XDH). This enzyme is consistently expressed and very active in non-malignant human mammary epithelial cells (HMEC), as opposed to tumour MDA-MB231 and MCF7 cells. In these latter two cell lines, as opposed to HMEC cells, we observe a residual ability of XDH to produce retinoic acid from retinaldehyde and the inability to use retinol, as a consequence of a deficit in CRBP. In addition, estradiol treatment of MDA-MB231 and MCF7 cells decreases protein expression and activity of the enzyme, with no modification of the mRNA transcript levels, eventually leading to deteriorate further retinoic acid production. J. Cell. Biochem. 108: 688–692, 2009. © 2009 Wiley-Liss, Inc.

https://doi.org/10.1002/jcb.22305